J CANCER RES CLIN 润色咨询

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

出版年份:1979 年文章数:3146 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192752, encodeId=e18d2192e5272, content=肿瘤领域还是比较好发的,有办法包accept,还没投的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/8162bc5d57234edb89dc546fca11f2b8-WHeBev04VHIs.jpg, createdBy=eb769208061, createdName=Tuo1887878, createdTime=Tue Mar 12 14:14:49 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=123, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向:肿瘤<br>经验分享:1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237643, encodeId=3dfd123e643cd, content=审稿速度:1.0<br>偏重的研究方向:胃癌;生信<br>经验分享:Journal of Cancer Research and Clinical Oncology,大部分为纯生信内容,几天就被拒了,优先级不够,被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Aug 09 17:19:39 CST 2022, time=2022-08-09, status=1, ipAttribution=)]
    2024-03-06 ms8000000280791103 来自重庆

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤;基础研究
    经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊

    8

    展开8条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192752, encodeId=e18d2192e5272, content=肿瘤领域还是比较好发的,有办法包accept,还没投的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/8162bc5d57234edb89dc546fca11f2b8-WHeBev04VHIs.jpg, createdBy=eb769208061, createdName=Tuo1887878, createdTime=Tue Mar 12 14:14:49 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=123, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向:肿瘤<br>经验分享:1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237643, encodeId=3dfd123e643cd, content=审稿速度:1.0<br>偏重的研究方向:胃癌;生信<br>经验分享:Journal of Cancer Research and Clinical Oncology,大部分为纯生信内容,几天就被拒了,优先级不够,被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Aug 09 17:19:39 CST 2022, time=2022-08-09, status=1, ipAttribution=)]
    2024-03-12 ms6000001537745536 来自四川省

    二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192752, encodeId=e18d2192e5272, content=肿瘤领域还是比较好发的,有办法包accept,还没投的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/8162bc5d57234edb89dc546fca11f2b8-WHeBev04VHIs.jpg, createdBy=eb769208061, createdName=Tuo1887878, createdTime=Tue Mar 12 14:14:49 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=123, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向:肿瘤<br>经验分享:1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237643, encodeId=3dfd123e643cd, content=审稿速度:1.0<br>偏重的研究方向:胃癌;生信<br>经验分享:Journal of Cancer Research and Clinical Oncology,大部分为纯生信内容,几天就被拒了,优先级不够,被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Aug 09 17:19:39 CST 2022, time=2022-08-09, status=1, ipAttribution=)]
    2024-03-13 ms9000000002911795 来自黑龙江省

    偏重的研究方向:肿瘤临床;肿瘤
    经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192752, encodeId=e18d2192e5272, content=肿瘤领域还是比较好发的,有办法包accept,还没投的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/8162bc5d57234edb89dc546fca11f2b8-WHeBev04VHIs.jpg, createdBy=eb769208061, createdName=Tuo1887878, createdTime=Tue Mar 12 14:14:49 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=123, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向:肿瘤<br>经验分享:1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237643, encodeId=3dfd123e643cd, content=审稿速度:1.0<br>偏重的研究方向:胃癌;生信<br>经验分享:Journal of Cancer Research and Clinical Oncology,大部分为纯生信内容,几天就被拒了,优先级不够,被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Aug 09 17:19:39 CST 2022, time=2022-08-09, status=1, ipAttribution=)]
    2024-02-01 ms6000001259041667 来自北京

    审稿速度:1.0
    偏重的研究方向:肿瘤
    经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192752, encodeId=e18d2192e5272, content=肿瘤领域还是比较好发的,有办法包accept,还没投的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/8162bc5d57234edb89dc546fca11f2b8-WHeBev04VHIs.jpg, createdBy=eb769208061, createdName=Tuo1887878, createdTime=Tue Mar 12 14:14:49 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=123, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向:肿瘤<br>经验分享:1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237643, encodeId=3dfd123e643cd, content=审稿速度:1.0<br>偏重的研究方向:胃癌;生信<br>经验分享:Journal of Cancer Research and Clinical Oncology,大部分为纯生信内容,几天就被拒了,优先级不够,被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Aug 09 17:19:39 CST 2022, time=2022-08-09, status=1, ipAttribution=)]
    2024-03-06 ms8000000280791103 来自重庆

    偏重的研究方向:肿瘤基础研究
    经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192752, encodeId=e18d2192e5272, content=肿瘤领域还是比较好发的,有办法包accept,还没投的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/8162bc5d57234edb89dc546fca11f2b8-WHeBev04VHIs.jpg, createdBy=eb769208061, createdName=Tuo1887878, createdTime=Tue Mar 12 14:14:49 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=123, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向:肿瘤<br>经验分享:1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237643, encodeId=3dfd123e643cd, content=审稿速度:1.0<br>偏重的研究方向:胃癌;生信<br>经验分享:Journal of Cancer Research and Clinical Oncology,大部分为纯生信内容,几天就被拒了,优先级不够,被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Aug 09 17:19:39 CST 2022, time=2022-08-09, status=1, ipAttribution=)]
    2024-03-12 Tuo1887878 来自广西

    肿瘤领域还是比较好发的,有办法包accept,还没投的可以聊聊

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192752, encodeId=e18d2192e5272, content=肿瘤领域还是比较好发的,有办法包accept,还没投的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/8162bc5d57234edb89dc546fca11f2b8-WHeBev04VHIs.jpg, createdBy=eb769208061, createdName=Tuo1887878, createdTime=Tue Mar 12 14:14:49 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=123, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向:肿瘤<br>经验分享:1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237643, encodeId=3dfd123e643cd, content=审稿速度:1.0<br>偏重的研究方向:胃癌;生信<br>经验分享:Journal of Cancer Research and Clinical Oncology,大部分为纯生信内容,几天就被拒了,优先级不够,被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Aug 09 17:19:39 CST 2022, time=2022-08-09, status=1, ipAttribution=)]
    2020-06-12 ms5502585941462392

    9月28投稿,10月7日直接接收,还以为是拒稿。😀

    123

    展开123条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192752, encodeId=e18d2192e5272, content=肿瘤领域还是比较好发的,有办法包accept,还没投的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/8162bc5d57234edb89dc546fca11f2b8-WHeBev04VHIs.jpg, createdBy=eb769208061, createdName=Tuo1887878, createdTime=Tue Mar 12 14:14:49 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=123, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向:肿瘤<br>经验分享:1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237643, encodeId=3dfd123e643cd, content=审稿速度:1.0<br>偏重的研究方向:胃癌;生信<br>经验分享:Journal of Cancer Research and Clinical Oncology,大部分为纯生信内容,几天就被拒了,优先级不够,被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Aug 09 17:19:39 CST 2022, time=2022-08-09, status=1, ipAttribution=)]
    2024-03-06 ms5000001486959246 来自北京

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向:肿瘤
    经验分享:还是比较快的
    Submission is in publishing and rights
    05 Mar 2024
    Peer review
    Submission status Date
    Submission accepted
    05 Mar 2024
    Submission under peer review
    16 Feb 2024
    Submission passed technical check
    16 Feb 2024
    Revision received
    15 Feb 2024
    Submission under peer review
    11 Jan 2024
    Technical check
    Submission status Date
    Submission passed technical check
    11 Jan 2024
    Submission is under technical check
    10 Jan 2024
    Submission received
    Submission status Date
    Submission received
    10 Jan 2024

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192752, encodeId=e18d2192e5272, content=肿瘤领域还是比较好发的,有办法包accept,还没投的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/8162bc5d57234edb89dc546fca11f2b8-WHeBev04VHIs.jpg, createdBy=eb769208061, createdName=Tuo1887878, createdTime=Tue Mar 12 14:14:49 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=123, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向:肿瘤<br>经验分享:1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237643, encodeId=3dfd123e643cd, content=审稿速度:1.0<br>偏重的研究方向:胃癌;生信<br>经验分享:Journal of Cancer Research and Clinical Oncology,大部分为纯生信内容,几天就被拒了,优先级不够,被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Aug 09 17:19:39 CST 2022, time=2022-08-09, status=1, ipAttribution=)]
    2024-01-25 ms6000001259041667 来自北京

    偏重的研究方向:肿瘤
    经验分享:1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊

    13

    展开13条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192752, encodeId=e18d2192e5272, content=肿瘤领域还是比较好发的,有办法包accept,还没投的可以聊聊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/8162bc5d57234edb89dc546fca11f2b8-WHeBev04VHIs.jpg, createdBy=eb769208061, createdName=Tuo1887878, createdTime=Tue Mar 12 14:14:49 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=123, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183905, encodeId=34682183905f8, content=偏重的研究方向:肿瘤<br>经验分享:1月16投的一天就过了技术审查 现在显示peer review 但是我看下面详情写着正在找合适的编辑管理文章 所以文章现在是审呢 还是还没有编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Jan 25 16:12:06 CST 2024, time=2024-01-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1237643, encodeId=3dfd123e643cd, content=审稿速度:1.0<br>偏重的研究方向:胃癌;生信<br>经验分享:Journal of Cancer Research and Clinical Oncology,大部分为纯生信内容,几天就被拒了,优先级不够,被拒。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Aug 09 17:19:39 CST 2022, time=2022-08-09, status=1, ipAttribution=)]
    2022-08-09 ms2000000713462597

    审稿速度:1.0
    偏重的研究方向:胃癌;生信
    经验分享:Journal of Cancer Research and Clinical Oncology,大部分为纯生信内容,几天就被拒了,优先级不够,被拒。

    3

    展开3条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分